Global pharmaceutical company Novartis plans to cut up to 400 jobs at its Dublin office over the next two years.
The Swiss-headquartered company will cut staff at its Global Service Center in Elm Park, Dublin.
The company said the move was a strategic decision as a result of a review of its operations.
However, the facility will continue to play a crucial role in terms of scientific and commercial operations, she stressed.
Novartis released a statement saying it “recognizes” the announcement would have “a significant impact on people and create uncertainty.”
It added that it was “committed to providing information to staff in the most transparent and timely manner possible”.
Around 1,000 people work at the facility. However, that number could be reduced to 600 over time, the company says.
Workers were notified this morning and a consultation process with workers’ representatives has now started.
The announcement comes after the company announced in April that it would be creating a new global organizational structure and operating model.
The company plans how best to increase growth and improve productivity.
The company also employs 500 people in Cork at a manufacturing facility in Ringaskiddy and a pharmaceuticals division in Dublin.
Novartis supplies medicines to 190,000 patients every year and the company says it has an economic activity of 295 million euros.
The company lists its five healthcare priorities as neuroscience, cardiology, immunology, oncology and hematology, with “strong positions” in technology platforms, including cell and gene therapies.
https://www.independent.ie/business/irish/drug-firm-novartis-to-cut-400-jobs-at-dublin-base-42064351.html The pharmaceutical company Novartis is cutting 400 jobs in Dublin